ABIRATERONE ACETATE

ABIRATERONE ACETATE was reported 41077 times

ABIRATERONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 29 0.4677
1 APPARENT MINERALOCORTICOID EXCESS 23 0.3966
2 HORMONE-DEPENDENT PROSTATE CANCER 21 0.3000
3 POLYNEUROPATHY IN MALIGNANT DISEASE 17 0.2073
4 PROSTATE CANCER METASTATIC 657 0.1965
5 NEUROENDOCRINE CARCINOMA OF PROSTATE 12 0.1765
6 PROSTATIC SPECIFIC ANTIGEN INCREASED 2016 0.1462
7 HEREDITARY OPTIC ATROPHY 9 0.1286
8 HORMONE-REFRACTORY PROSTATE CANCER 152 0.1279
9 BRCA2 GENE MUTATION 12 0.1263
10 BRCA1 GENE MUTATION 11 0.1250
11 ACUTE BIPHENOTYPIC LEUKAEMIA 11 0.1183
12 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 103 0.0992
13 PROSTATIC SPECIFIC ANTIGEN DECREASED 37 0.0979
14 HYPERALDOSTERONISM 25 0.0725
15 PROSTATE CANCER RECURRENT 39 0.0633
16 METASTASES TO NERVOUS SYSTEM 9 0.0489
17 METASTASES TO SOFT TISSUE 12 0.0463
18 PRODUCT DIFFICULT TO SWALLOW 44 0.0433
19 SPINAL CORD INFARCTION 15 0.0340
20 ACQUIRED HAEMOPHILIA 34 0.0339
21 METASTASES TO BLADDER 9 0.0316
22 GASTRODUODENAL ULCER 13 0.0309
23 RETROPERITONEAL LYMPHADENOPATHY 16 0.0304
24 NEPHROSTOMY 10 0.0303
25 THERAPY CESSATION 1550 0.0302
26 HYDROURETER 11 0.0289
27 PENILE OEDEMA 9 0.0276
28 METASTASES TO BONE 453 0.0276
29 BONE CANCER METASTATIC 14 0.0265
30 CHEMOTHERAPY 97 0.0256
31 HOSPICE CARE 251 0.0254
32 METASTASES TO SPINE 84 0.0250
33 METABOLIC ALKALOSIS 40 0.0249
34 TRANSURETHRAL PROSTATECTOMY 12 0.0240
35 PRODUCT SIZE ISSUE 122 0.0227
36 RADIOTHERAPY 43 0.0225
37 METASTASES TO BONE MARROW 11 0.0220
38 SOFT TISSUE MASS 10 0.0216
39 BONE SCAN ABNORMAL 9 0.0212
40 URINARY TRACT OBSTRUCTION 50 0.0211
41 SPINAL CORD COMPRESSION 78 0.0200
42 HOT FLUSH 1503 0.0199
43 BLOOD CHROMOGRANIN A INCREASED 9 0.0196
44 METASTASES TO PELVIS 12 0.0190
45 BLADDER OBSTRUCTION 9 0.0175
46 CANCER PAIN 43 0.0168
47 HYPOKALAEMIA 761 0.0165
48 PROSTATECTOMY 9 0.0157
49 RADIATION INJURY 16 0.0150
50 URINARY BLADDER HAEMORRHAGE 31 0.0147
51 URETHRAL STENOSIS 10 0.0146
52 HAEMORRHAGE URINARY TRACT 37 0.0145
53 BONE LESION 51 0.0141
54 SPINAL CORD NEOPLASM 12 0.0138
55 ALLODYNIA 16 0.0137
56 METASTASES TO LYMPH NODES 92 0.0136
57 BLOOD TESTOSTERONE INCREASED 28 0.0130
58 THYROID HORMONES DECREASED 10 0.0125
59 BLOOD TESTOSTERONE ABNORMAL 13 0.0117
60 HYDRONEPHROSIS 88 0.0117
61 PROSTATIC OPERATION 14 0.0116
62 PROSTATE CANCER 923 0.0115
63 SYSTEMIC INFECTION 19 0.0115
64 LONG QT SYNDROME 27 0.0112
65 ACUTE CORONARY SYNDROME 86 0.0104
66 ABDOMINAL LYMPHADENOPATHY 9 0.0104
67 DISEASE PROGRESSION 1226 0.0104
68 BONE CANCER 45 0.0103
69 OSTEONECROSIS OF JAW 240 0.0097
70 PYELONEPHRITIS ACUTE 19 0.0097
71 BONE NEOPLASM 10 0.0093
72 GASTROINTESTINAL TUBE INSERTION 23 0.0092
73 GASTROENTERITIS NOROVIRUS 12 0.0090
74 GASTROSTOMY 14 0.0090
75 PATHOLOGICAL FRACTURE 45 0.0089
76 RHABDOMYOLYSIS 364 0.0087
77 METASTASIS 62 0.0087
78 METASTASES TO LUNG 99 0.0086
79 BLOOD POTASSIUM DECREASED 257 0.0085
80 UROSEPSIS 78 0.0084
81 BLADDER NEOPLASM 14 0.0082
82 HEPATITIS FULMINANT 24 0.0081
83 CALCULUS BLADDER 11 0.0081
84 SECONDARY ADRENOCORTICAL INSUFFICIENCY 12 0.0079
85 BLOOD ALKALINE PHOSPHATASE INCREASED 197 0.0079
86 HYPOPROTEINAEMIA 15 0.0079
87 HAEMATURIA 270 0.0079
88 ADRENAL INSUFFICIENCY 95 0.0078
89 METASTASES TO LIVER 137 0.0078
90 THERAPY INTERRUPTED 556 0.0078
91 METASTATIC NEOPLASM 33 0.0076
92 FOREIGN BODY IN RESPIRATORY TRACT 10 0.0076
93 MALIGNANT NEOPLASM PROGRESSION 781 0.0076
94 NOCTURIA 90 0.0074
95 THERAPY CHANGE 71 0.0072
96 DEATH 6210 0.0072
97 HOSPITALISATION 1095 0.0071
98 BLOOD URINE PRESENT 135 0.0071
99 PROSTATE CANCER STAGE IV 25 0.0070
100 HAEMORRHAGE SUBCUTANEOUS 25 0.0070
101 FANCONI SYNDROME ACQUIRED 12 0.0068
102 HYPOPHOSPHATAEMIA 49 0.0066
103 PALLIATIVE CARE 10 0.0065
104 HEPATOTOXICITY 145 0.0065
105 BLOOD POTASSIUM ABNORMAL 17 0.0064
106 ALVEOLITIS 9 0.0064
107 OSTEOSCLEROSIS 10 0.0063
108 MUSCLE ATROPHY 78 0.0062
109 ADRENOCORTICAL INSUFFICIENCY ACUTE 12 0.0061
110 TORSADE DE POINTES 47 0.0060
111 OSTEITIS 15 0.0059
112 CATHETER PLACEMENT 11 0.0059
113 CUSHINGOID 19 0.0059
114 PARAPLEGIA 17 0.0059
115 BLOOD TESTOSTERONE DECREASED 40 0.0058
116 HEPATIC FUNCTION ABNORMAL 217 0.0058
117 BLOOD PHOSPHORUS DECREASED 21 0.0057
118 TESTICULAR PAIN 18 0.0057
119 PARAPARESIS 10 0.0056
120 PROSTATITIS 17 0.0056
121 PRODUCT USE COMPLAINT 88 0.0056
122 DRUG-INDUCED LIVER INJURY 175 0.0056
123 OPHTHALMIC HERPES ZOSTER 10 0.0055
124 PROSTATOMEGALY 21 0.0053
125 URINARY RETENTION 177 0.0053
126 LIVER FUNCTION TEST ABNORMAL 153 0.0053
127 OSTEOPOROTIC FRACTURE 10 0.0052
128 CHOLECYSTITIS ACUTE 29 0.0051
129 EXPOSED BONE IN JAW 11 0.0051
130 LIVER FUNCTION TEST INCREASED 108 0.0050
131 URINE FLOW DECREASED 12 0.0050
132 HYPOCALCAEMIA 95 0.0050
133 POLLAKIURIA 209 0.0050
134 URINE OUTPUT INCREASED 13 0.0050
135 CRANIOCEREBRAL INJURY 15 0.0050
136 LARGE INTESTINAL OBSTRUCTION 11 0.0049
137 ESSENTIAL HYPERTENSION 9 0.0049
138 SKIN ATROPHY 28 0.0049
139 ELECTROLYTE IMBALANCE 56 0.0048
140 ACUTE PULMONARY OEDEMA 27 0.0048
141 LYMPHOEDEMA 33 0.0048
142 FOREIGN BODY IN THROAT 15 0.0048
143 STENT PLACEMENT 38 0.0047
144 JAW FRACTURE 10 0.0046
145 NONSPECIFIC REACTION 25 0.0046
146 DYSPHAGIA 432 0.0045
147 ABNORMAL LOSS OF WEIGHT 31 0.0045
148 BRAIN FOG 71 0.0045
149 RIB FRACTURE 93 0.0045
150 ADVERSE EVENT 416 0.0045
151 CARDIAC FAILURE ACUTE 30 0.0045
152 BLOOD BLISTER 14 0.0045
153 DEVICE RELATED SEPSIS 9 0.0045
154 INVESTIGATION 14 0.0045
155 FAILURE TO THRIVE 23 0.0044
156 ALANINE AMINOTRANSFERASE INCREASED 271 0.0044
157 OEDEMA PERIPHERAL 538 0.0044
158 METASTASES TO MENINGES 10 0.0044
159 DISEASE COMPLICATION 20 0.0044
160 PRESCRIBED UNDERDOSE 87 0.0044
161 CARDIAC FAILURE 349 0.0043
162 ATYPICAL PNEUMONIA 13 0.0043
163 TERMINAL STATE 29 0.0043
164 BONE PAIN 253 0.0043
165 OEDEMA 232 0.0043
166 PHYSICAL DECONDITIONING 11 0.0043
167 SPINAL COMPRESSION FRACTURE 35 0.0042
168 ATRIAL FIBRILLATION 412 0.0042
169 URINARY TRACT DISORDER 19 0.0042
170 GROIN PAIN 37 0.0042
171 BLOOD MAGNESIUM DECREASED 36 0.0042
172 URINARY TRACT INFECTION 709 0.0042
173 CARDIOTOXICITY 37 0.0041
174 NON-CARDIAC CHEST PAIN 13 0.0041
175 FEMORAL NECK FRACTURE 21 0.0041
176 ASPARTATE AMINOTRANSFERASE INCREASED 217 0.0041
177 DYSURIA 150 0.0041
178 HYPERGLYCAEMIA 148 0.0041
179 CERVICAL VERTEBRAL FRACTURE 14 0.0041
180 INTERNAL HAEMORRHAGE 46 0.0040
181 INCREASED TENDENCY TO BRUISE 37 0.0040
182 SKIN ABRASION 19 0.0040
183 DERMATOMYOSITIS 10 0.0039
184 HEPATIC ENZYME INCREASED 266 0.0039
185 NIGHT SWEATS 125 0.0039
186 LIVER DISORDER 171 0.0039
187 FLUID RETENTION 196 0.0038
188 TRANSAMINASES INCREASED 85 0.0038
189 HEPATIC ENZYME ABNORMAL 19 0.0038
190 ANAEMIA 723 0.0038
191 HYPERTENSION 796 0.0038
192 DUODENAL ULCER 26 0.0037
193 HAEMATOLOGICAL INFECTION 9 0.0037
194 EMERGENCY CARE 11 0.0036
195 FLANK PAIN 34 0.0036
196 MUSCULOSKELETAL CHEST PAIN 56 0.0036
197 INCONTINENCE 38 0.0036
198 CORONARY ARTERY STENOSIS 18 0.0036
199 LUNG CONSOLIDATION 10 0.0036
200 OESOPHAGITIS 39 0.0036
201 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
202 ASTHENIA 1324 0.0035
203 SEPSIS 391 0.0035
204 MICTURITION URGENCY 40 0.0035
205 FATIGUE 2709 0.0035
206 MICTURITION DISORDER 12 0.0035
207 HYPERTRANSAMINASAEMIA 24 0.0034
208 HYPERVOLAEMIA 17 0.0034
209 IMMOBILE 15 0.0034
210 HYPERTENSIVE CRISIS 38 0.0034
211 DECREASED APPETITE 789 0.0034
212 CLAVICLE FRACTURE 13 0.0034
213 AORTIC DISSECTION 14 0.0034
214 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
215 MUSCULAR WEAKNESS 383 0.0034
216 DRUG DOSE OMISSION 556 0.0034
217 LABORATORY TEST ABNORMAL 98 0.0033
218 HIP FRACTURE 106 0.0033
219 DRUG INTERACTION 522 0.0033
220 ACUTE KIDNEY INJURY 503 0.0033
221 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
222 BLOOD BILIRUBIN INCREASED 88 0.0033
223 METASTASES TO CENTRAL NERVOUS SYSTEM 42 0.0033
224 ISCHAEMIC STROKE 57 0.0032
225 ACUTE MYOCARDIAL INFARCTION 94 0.0032
226 URINARY INCONTINENCE 94 0.0032
227 TRANSIENT ISCHAEMIC ATTACK 107 0.0032
228 BLADDER PAIN 10 0.0031
229 CARDIAC OPERATION 27 0.0031
230 HYPERKALAEMIA 110 0.0031
231 GENERAL PHYSICAL HEALTH DETERIORATION 361 0.0031
232 THROMBOCYTOPENIA 348 0.0031
233 HYPERBILIRUBINAEMIA 32 0.0031
234 VENTRICULAR FIBRILLATION 34 0.0031
235 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
236 KIDNEY INFECTION 60 0.0031
237 THORACIC VERTEBRAL FRACTURE 9 0.0030
238 BLOOD CALCIUM DECREASED 34 0.0030
239 CARDIAC PACEMAKER INSERTION 18 0.0030
240 FRACTURE 57 0.0030
241 LIPASE INCREASED 23 0.0030
242 PERFORMANCE STATUS DECREASED 14 0.0030
243 FOREIGN BODY 12 0.0030
244 PLEURAL EFFUSION 182 0.0030
245 GENERALISED OEDEMA 37 0.0030
246 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
247 PRODUCT DOSE OMISSION 194 0.0030
248 HIP SURGERY 16 0.0030
249 PERIPHERAL SWELLING 454 0.0029
250 DEHYDRATION 393 0.0029
251 DEMENTIA 82 0.0029
252 SUDDEN DEATH 31 0.0029
253 SPINAL STENOSIS 12 0.0029
254 LEFT VENTRICULAR FAILURE 10 0.0029
255 MYOPATHY 25 0.0029
256 INTERSTITIAL LUNG DISEASE 140 0.0029
257 PYELONEPHRITIS 25 0.0029
258 FALL 956 0.0029
259 REHABILITATION THERAPY 11 0.0028
260 POLYNEUROPATHY 34 0.0028
261 WOUND SECRETION 11 0.0028
262 DRUG RESISTANCE 72 0.0028
263 GAMMA-GLUTAMYLTRANSFERASE INCREASED 62 0.0028
264 PNEUMOCYSTIS JIROVECII PNEUMONIA 28 0.0028
265 VENTRICULAR TACHYCARDIA 46 0.0028
266 DIZZINESS POSTURAL 27 0.0028
267 DIABETES MELLITUS 212 0.0028
268 PULMONARY THROMBOSIS 30 0.0027
269 HEPATOCELLULAR INJURY 39 0.0027
270 HYPERTRIGLYCERIDAEMIA 16 0.0027
271 CYSTITIS 87 0.0027
272 BLOOD PRESSURE ABNORMAL 54 0.0027
273 DIABETES MELLITUS INADEQUATE CONTROL 48 0.0027
274 COVID-19 PNEUMONIA 32 0.0027
275 AMYLASE INCREASED 10 0.0027
276 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
277 HYPOALBUMINAEMIA 21 0.0027
278 CONSTIPATION 589 0.0027
279 HEART RATE IRREGULAR 61 0.0027
280 SPINAL FRACTURE 54 0.0027
281 SYNCOPE 268 0.0027
282 TRANSFUSION 28 0.0027
283 HYPOMAGNESAEMIA 37 0.0027
284 MYOCARDIAL ISCHAEMIA 30 0.0026
285 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
286 ADVERSE DRUG REACTION 235 0.0026
287 QUALITY OF LIFE DECREASED 35 0.0026
288 GINGIVAL DISORDER 10 0.0026
289 NEPHROLITHIASIS 119 0.0026
290 SUBDURAL HAEMATOMA 37 0.0026
291 AORTIC STENOSIS 9 0.0026
292 NEPHROPATHY TOXIC 29 0.0026
293 ERYTHEMA MULTIFORME 24 0.0026
294 LYMPHADENOPATHY 91 0.0026
295 CORONARY ARTERIAL STENT INSERTION 13 0.0026
296 EMBOLIC STROKE 9 0.0026
297 HYPERAESTHESIA 21 0.0026
298 BLOOD SODIUM DECREASED 48 0.0025
299 DERMATITIS ALLERGIC 32 0.0025
300 PNEUMONITIS 69 0.0025
301 HAEMORRHAGIC DIATHESIS 9 0.0025
302 HAEMATOTOXICITY 24 0.0025
303 GASTRIC ULCER 48 0.0025
304 INCORRECT DOSE ADMINISTERED 570 0.0025
305 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
306 RECTAL HAEMORRHAGE 107 0.0025
307 BLOOD PRESSURE INCREASED 380 0.0025
308 BLOOD POTASSIUM INCREASED 40 0.0025
309 RENAL TUBULAR NECROSIS 24 0.0024
310 POLYURIA 20 0.0024
311 EXERCISE TOLERANCE DECREASED 14 0.0024
312 HEPATIC CYTOLYSIS 31 0.0024
313 NEOPLASM MALIGNANT 162 0.0024
314 COMPRESSION FRACTURE 13 0.0024
315 NEOPLASM PROGRESSION 84 0.0024
316 METABOLIC DISORDER 14 0.0024
317 HYPERNATRAEMIA 12 0.0024
318 ARRHYTHMIA 113 0.0024
319 BACK PAIN 549 0.0024
320 ELECTROCARDIOGRAM QT PROLONGED 85 0.0024
321 BEDRIDDEN 31 0.0024
322 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
323 SPINAL OPERATION 29 0.0024
324 AORTIC VALVE INCOMPETENCE 10 0.0023
325 RED BLOOD CELL COUNT DECREASED 67 0.0023
326 DRUG PRESCRIBING ERROR 45 0.0023
327 HYPERSOMNIA 67 0.0023
328 PULMONARY EMBOLISM 222 0.0023
329 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
330 HEPATIC LESION 10 0.0023
331 HYPONATRAEMIA 130 0.0023
332 THERAPY PARTIAL RESPONDER 36 0.0023
333 PNEUMONIA 747 0.0023
334 SPINAL PAIN 27 0.0023
335 CHROMATURIA 52 0.0023
336 MONOPLEGIA 10 0.0023
337 PULMONARY OEDEMA 103 0.0023
338 SURGERY 134 0.0023
339 HUMERUS FRACTURE 11 0.0023
340 BLOOD TEST ABNORMAL 32 0.0023
341 WALKING AID USER 15 0.0023
342 CEREBRAL HAEMORRHAGE 81 0.0023
343 ATRIAL FLUTTER 18 0.0023
344 CONTUSION 217 0.0023
345 HAEMOGLOBIN DECREASED 231 0.0022
346 WHEELCHAIR USER 10 0.0022
347 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
348 CARDIAC FAILURE CONGESTIVE 179 0.0022
349 GINGIVITIS 12 0.0022
350 WEIGHT DECREASED 621 0.0022
351 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
352 PLATELET COUNT DECREASED 235 0.0022
353 SARS-COV-2 TEST POSITIVE 29 0.0022
354 DRUG EFFECT DECREASED 118 0.0022
355 HEPATIC FAILURE 66 0.0022
356 LEG AMPUTATION 9 0.0022
357 ODYNOPHAGIA 13 0.0022
358 TREATMENT NONCOMPLIANCE 119 0.0022
359 RENAL PAIN 23 0.0022
360 GASTRIC ULCER HAEMORRHAGE 12 0.0022
361 INCOHERENT 14 0.0022
362 MUSCULOSKELETAL PAIN 113 0.0022
363 ARTHRITIS INFECTIVE 10 0.0022
364 GAIT INABILITY 72 0.0022
365 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
366 VITAMIN D DEFICIENCY 21 0.0022
367 PELVIC PAIN 39 0.0021
368 ENDOCARDITIS 11 0.0021
369 ERECTILE DYSFUNCTION 55 0.0021
370 CACHEXIA 11 0.0021
371 GASTRITIS 56 0.0021
372 MUSCLE FATIGUE 9 0.0021
373 PNEUMONIA ASPIRATION 53 0.0021
374 TASTE DISORDER 43 0.0021
375 SKIN LACERATION 23 0.0021
376 INTERVERTEBRAL DISC DISORDER 9 0.0021
377 CORONARY ARTERY BYPASS 12 0.0021
378 GASTROINTESTINAL TOXICITY 10 0.0021
379 HYPOPHAGIA 53 0.0021
380 ULCER HAEMORRHAGE 14 0.0021
381 BODY HEIGHT DECREASED 22 0.0021
382 THERAPEUTIC PRODUCT EFFECT DECREASED 92 0.0021
383 FOOD POISONING 11 0.0021
384 EMBOLISM 17 0.0020
385 GASTRIC DISORDER 70 0.0020
386 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
387 CONFUSIONAL STATE 329 0.0020
388 MYOCARDIAL INFARCTION 355 0.0020
389 DRUG ERUPTION 36 0.0020
390 BONE DISORDER 37 0.0020
391 LOWER RESPIRATORY TRACT INFECTION 92 0.0020
392 HAEMOGLOBIN ABNORMAL 13 0.0020
393 BLADDER DISORDER 20 0.0020
394 CARDIAC DISORDER 188 0.0020
395 GASTRIC HAEMORRHAGE 23 0.0020
396 LIVER INJURY 49 0.0020
397 NECROSIS 11 0.0020
398 ACUTE HEPATIC FAILURE 27 0.0020
399 INGUINAL HERNIA 12 0.0020
400 AORTIC ANEURYSM 15 0.0020
401 BALANCE DISORDER 170 0.0020
402 MUSCLE STRAIN 17 0.0020
403 LETHARGY 113 0.0020
404 TOOTH ABSCESS 20 0.0020
405 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
406 APPETITE DISORDER 13 0.0020
407 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
408 HIP ARTHROPLASTY 30 0.0020
409 LOCALISED OEDEMA 9 0.0019
410 HYPERCALCAEMIA 24 0.0019
411 CEREBRAL ISCHAEMIA 10 0.0019
412 RENAL FUNCTION TEST ABNORMAL 9 0.0019
413 RENAL IMPAIRMENT 162 0.0019
414 HAEMORRHAGIC STROKE 15 0.0019
415 NEOPLASM 22 0.0019
416 SPINAL COLUMN STENOSIS 9 0.0019
417 JOINT DISLOCATION 20 0.0019
418 FULL BLOOD COUNT ABNORMAL 20 0.0019
419 LOSS OF LIBIDO 17 0.0019
420 HYPERHIDROSIS 243 0.0019
421 ANGINA PECTORIS 54 0.0019
422 DEVICE RELATED INFECTION 29 0.0019
423 ABSCESS 30 0.0019
424 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
425 EATING DISORDER 40 0.0019
426 NEUROPATHY PERIPHERAL 178 0.0019
427 URINE ODOUR ABNORMAL 11 0.0019
428 PANCREATITIS ACUTE 42 0.0019
429 THROMBOSIS 150 0.0019
430 CEREBROVASCULAR ACCIDENT 314 0.0019
431 RENAL DISORDER 86 0.0018
432 NERVE COMPRESSION 17 0.0018
433 INCORRECT DOSAGE ADMINISTERED 9 0.0018
434 INCREASED APPETITE 35 0.0018
435 WEIGHT INCREASED 409 0.0018
436 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 129 0.0018
437 PROSTATIC DISORDER 10 0.0018
438 MUSCULOSKELETAL DISCOMFORT 31 0.0018
439 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0018
440 RASH MACULO-PAPULAR 40 0.0018
441 CHOKING 35 0.0018
442 HEART RATE ABNORMAL 10 0.0018
443 SEPTIC SHOCK 78 0.0018
444 HYPOKINESIA 26 0.0018
445 EMPHYSEMA 18 0.0018
446 MYOSITIS 16 0.0018
447 DYSSTASIA 52 0.0018
448 TOE AMPUTATION 9 0.0018
449 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
450 PRESYNCOPE 43 0.0018
451 RESTLESS LEGS SYNDROME 32 0.0018
452 SCIATICA 28 0.0018
453 PNEUMONIA BACTERIAL 16 0.0017
454 BLOOD GLUCOSE FLUCTUATION 19 0.0017
455 MYASTHENIA GRAVIS 14 0.0017
456 LARGE INTESTINE POLYP 12 0.0017
457 DELIRIUM 60 0.0017
458 PRODUCT DISTRIBUTION ISSUE 16 0.0017
459 RENAL FAILURE 229 0.0017
460 TOOTH FRACTURE 19 0.0017
461 EXTRASYSTOLES 12 0.0017
462 DEVICE OCCLUSION 24 0.0017
463 ARTERIOSCLEROSIS 16 0.0017
464 PROCEDURAL COMPLICATION 13 0.0017
465 PURPURA 15 0.0017
466 DIZZINESS 843 0.0017
467 BLOOD GLUCOSE INCREASED 318 0.0017
468 PRODUCT ADMINISTRATION ERROR 34 0.0017
469 DYSPNOEA EXERTIONAL 63 0.0017
470 ORAL CANDIDIASIS 22 0.0017
471 ANAL INCONTINENCE 15 0.0017
472 INITIAL INSOMNIA 17 0.0017
473 ATELECTASIS 16 0.0017
474 FAECALOMA 9 0.0016
475 PNEUMOTHORAX 26 0.0016
476 VENTRICULAR EXTRASYSTOLES 17 0.0016
477 JAUNDICE 44 0.0016
478 INTESTINAL ISCHAEMIA 9 0.0016
479 DEEP VEIN THROMBOSIS 106 0.0016
480 LYMPHOPENIA 23 0.0016
481 WEIGHT FLUCTUATION 17 0.0016
482 BLOOD DISORDER 13 0.0016
483 PRODUCT LABEL ISSUE 11 0.0016
484 LIGAMENT SPRAIN 16 0.0016
485 GOUT 29 0.0016
486 BLOOD UREA INCREASED 27 0.0016
487 PULMONARY MASS 24 0.0016
488 INFARCTION 11 0.0016
489 TOOTH EXTRACTION 20 0.0016
490 PARALYSIS 23 0.0016
491 MUSCLE DISORDER 13 0.0016
492 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
493 AGEUSIA 40 0.0016
494 FACE OEDEMA 27 0.0016
495 POST PROCEDURAL INFECTION 13 0.0016
496 DECUBITUS ULCER 13 0.0016
497 TOOTH INFECTION 21 0.0016
498 ADVERSE REACTION 21 0.0016
499 HEAD INJURY 50 0.0016
500 TROPONIN INCREASED 12 0.0016
501 MYALGIA 268 0.0016
502 BONE MARROW FAILURE 32 0.0016
503 JOINT SWELLING 190 0.0016
504 MOOD SWINGS 50 0.0016
505 BOWEL MOVEMENT IRREGULARITY 12 0.0016
506 SECOND PRIMARY MALIGNANCY 13 0.0016
507 ACUTE RESPIRATORY FAILURE 30 0.0016
508 PERICARDIAL EFFUSION 36 0.0016
509 CEREBRAL INFARCTION 38 0.0016
510 ASPIRATION 17 0.0016
511 RETCHING 33 0.0015
512 COLON CANCER 23 0.0015
513 DIPLOPIA 40 0.0015
514 LEUKOPENIA 77 0.0015
515 HAEMORRHOIDS 30 0.0015
516 LOCALISED INFECTION 37 0.0015
517 CELLULITIS 77 0.0015
518 DIARRHOEA 985 0.0015
519 RETINAL DETACHMENT 14 0.0015
520 PRODUCT PRESCRIBING ERROR 36 0.0015
521 DRUG INEFFECTIVE 1989 0.0015
522 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
523 INTERNATIONAL NORMALISED RATIO INCREASED 43 0.0015
524 HAEMATOCHEZIA 83 0.0015
525 PANCYTOPENIA 84 0.0015
526 ORAL DISORDER 11 0.0015
527 APPENDICITIS 14 0.0015
528 GASTROENTERITIS VIRAL 27 0.0015
529 INFECTION 216 0.0015
530 TOOTHACHE 27 0.0015
531 BACK INJURY 16 0.0015
532 RESPIRATORY FAILURE 107 0.0015
533 INTESTINAL OBSTRUCTION 55 0.0015
534 MYELODYSPLASTIC SYNDROME 21 0.0015
535 CHOLANGITIS 9 0.0015
536 HERNIA 28 0.0014
537 LARGE INTESTINE PERFORATION 10 0.0014
538 ACIDOSIS 11 0.0014
539 FORMICATION 10 0.0014
540 OSTEOMYELITIS 26 0.0014
541 LIMB INJURY 39 0.0014
542 COORDINATION ABNORMAL 20 0.0014
543 VOMITING 673 0.0014
544 CHEST PAIN 265 0.0014
545 COVID-19 251 0.0014
546 MALNUTRITION 16 0.0014
547 VERTIGO 87 0.0014
548 ATRIOVENTRICULAR BLOCK 11 0.0014
549 PAIN IN EXTREMITY 419 0.0014
550 EJECTION FRACTION DECREASED 22 0.0014
551 HAND FRACTURE 10 0.0014
552 ARTHRALGIA 586 0.0014
553 HEPATITIS 36 0.0014
554 UPPER LIMB FRACTURE 28 0.0014
555 ABDOMINAL DISCOMFORT 235 0.0014
556 PROCTALGIA 9 0.0014
557 DYSPNOEA 792 0.0014
558 NO THERAPEUTIC RESPONSE 17 0.0014
559 POOR QUALITY DRUG ADMINISTERED 9 0.0014
560 DISORIENTATION 55 0.0014
561 CARDIAC MURMUR 12 0.0014
562 HEPATITIS ACUTE 9 0.0014
563 NEUTROPENIA 188 0.0014
564 GINGIVAL PAIN 11 0.0014
565 TENDON RUPTURE 17 0.0014
566 LOCAL SWELLING 24 0.0014
567 URINE OUTPUT DECREASED 12 0.0014
568 DIVERTICULITIS 38 0.0014
569 GASTROENTERITIS 20 0.0014
570 BLOOD CALCIUM INCREASED 12 0.0014
571 SPINAL OSTEOARTHRITIS 12 0.0014
572 GASTROINTESTINAL HAEMORRHAGE 114 0.0014
573 MELAENA 30 0.0014
574 ROAD TRAFFIC ACCIDENT 57 0.0014
575 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
576 CORONAVIRUS INFECTION 9 0.0014
577 FEBRILE NEUTROPENIA 90 0.0014
578 SHOCK HAEMORRHAGIC 11 0.0013
579 MALAISE 592 0.0013
580 ARTHROPOD BITE 10 0.0013
581 BLOOD CREATININE INCREASED 88 0.0013
582 HYPERCHOLESTEROLAEMIA 13 0.0013
583 LOSS OF CONSCIOUSNESS 172 0.0013
584 INSOMNIA 357 0.0013
585 CARDIOVASCULAR DISORDER 34 0.0013
586 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
587 PHOTOSENSITIVITY REACTION 22 0.0013
588 DYSPEPSIA 131 0.0013
589 FEELING COLD 37 0.0013
590 LUNG DISORDER 65 0.0013
591 MITRAL VALVE INCOMPETENCE 15 0.0013
592 NEUTROPHIL COUNT DECREASED 54 0.0013
593 HYPOTENSION 265 0.0013
594 RENAL FAILURE ACUTE 56 0.0013
595 ECCHYMOSIS 9 0.0013
596 THERAPY NON-RESPONDER 59 0.0013
597 MUSCLE SPASMS 240 0.0013
598 RESPIRATORY TRACT INFECTION 34 0.0013
599 TOOTH DISORDER 29 0.0013
600 PULMONARY FIBROSIS 25 0.0013
601 HYPOTONIA 13 0.0013
602 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
603 NAUSEA 1030 0.0013
604 LYMPHOCYTE COUNT DECREASED 23 0.0013
605 MENTAL STATUS CHANGES 36 0.0013
606 ASCITES 38 0.0013
607 DYSGEUSIA 96 0.0013
608 FEMUR FRACTURE 40 0.0013
609 AMNESIA 84 0.0013
610 PRODUCT PHYSICAL ISSUE 26 0.0013
611 MASS 18 0.0013
612 ILEUS 16 0.0013
613 ACUTE MYELOID LEUKAEMIA 20 0.0013
614 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
615 ANURIA 11 0.0013
616 CHOLECYSTITIS 15 0.0013
617 ULCER 20 0.0013
618 INFLUENZA 140 0.0013
619 THERAPEUTIC RESPONSE DECREASED 76 0.0013
620 BLOOD COUNT ABNORMAL 19 0.0013
621 CARDIAC ARREST 103 0.0012
622 GLAUCOMA 24 0.0012
623 DRY MOUTH 101 0.0012
624 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
625 OFF LABEL USE 1085 0.0012
626 FAECES SOFT 9 0.0012
627 BLOOD PRESSURE DECREASED 82 0.0012
628 GAIT DISTURBANCE 236 0.0012
629 BACTERIAL INFECTION 23 0.0012
630 THIRST 22 0.0012
631 HYPOACUSIS 53 0.0012
632 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
633 ASPHYXIA 10 0.0012
634 LUNG INFECTION 19 0.0012
635 SMALL INTESTINAL OBSTRUCTION 15 0.0012
636 HERPES ZOSTER 70 0.0012
637 OSTEONECROSIS 40 0.0012
638 SKIN HAEMORRHAGE 18 0.0012
639 WRONG TECHNIQUE IN DRUG USAGE PROCESS 44 0.0012
640 HAEMATOCRIT DECREASED 24 0.0012
641 DRUG LEVEL INCREASED 20 0.0012
642 SKIN CANCER 26 0.0012
643 TREATMENT FAILURE 100 0.0012
644 RESPIRATORY DISORDER 36 0.0012
645 COGNITIVE DISORDER 56 0.0012
646 FAECES DISCOLOURED 26 0.0012
647 MALIGNANT MELANOMA 16 0.0012
648 BLOOD GLUCOSE ABNORMAL 22 0.0012
649 EPISTAXIS 89 0.0012
650 HEPATOCELLULAR CARCINOMA 9 0.0012
651 BLOOD IRON DECREASED 14 0.0012
652 BODY TEMPERATURE INCREASED 24 0.0012
653 HYPOGLYCAEMIA 57 0.0012
654 ABASIA 29 0.0012
655 ACCIDENT 14 0.0012
656 LACERATION 11 0.0012
657 EMOTIONAL DISORDER 36 0.0012
658 OSTEOPOROSIS 48 0.0012
659 LEUKAEMIA 11 0.0012
660 FLATULENCE 66 0.0012
661 CONCUSSION 9 0.0012
662 INTESTINAL PERFORATION 13 0.0012
663 CORONARY ARTERY DISEASE 35 0.0012
664 SKIN DISCOLOURATION 53 0.0012
665 PETECHIAE 12 0.0011
666 MEMORY IMPAIRMENT 158 0.0011
667 ORTHOSTATIC HYPOTENSION 20 0.0011
668 POST PROCEDURAL COMPLICATION 22 0.0011
669 DRUG INTOLERANCE 110 0.0011
670 HAEMORRHAGE INTRACRANIAL 17 0.0011
671 TUMOUR LYSIS SYNDROME 10 0.0011
672 SWELLING FACE 74 0.0011
673 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 59 0.0011
674 ABDOMINAL DISTENSION 118 0.0011
675 AGRANULOCYTOSIS 21 0.0011
676 PAIN IN JAW 32 0.0011
677 HEPATIC STEATOSIS 21 0.0011
678 JOINT INJURY 24 0.0011
679 SLEEP DISORDER 79 0.0011
680 HAEMORRHAGE 117 0.0011
681 GASTROINTESTINAL INFECTION 10 0.0011
682 COLITIS 42 0.0011
683 HEART RATE INCREASED 109 0.0011
684 ESCHERICHIA INFECTION 9 0.0011
685 BRAIN NEOPLASM 10 0.0011
686 MOBILITY DECREASED 78 0.0011
687 BLOOD PRESSURE FLUCTUATION 26 0.0011
688 HUNGER 15 0.0011
689 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
690 PYREXIA 372 0.0011
691 MIDDLE INSOMNIA 20 0.0011
692 ABDOMINAL PAIN LOWER 27 0.0011
693 CHILLS 125 0.0011
694 CYTOPENIA 13 0.0011
695 FACIAL PARALYSIS 9 0.0011
696 ABDOMINAL PAIN UPPER 217 0.0011
697 PRODUCT PACKAGING ISSUE 10 0.0011
698 LEUKOCYTOSIS 19 0.0010
699 HYPOAESTHESIA 157 0.0010
700 BACK DISORDER 17 0.0010
701 CARDIOGENIC SHOCK 15 0.0010
702 PAIN 642 0.0010
703 FULL BLOOD COUNT DECREASED 21 0.0010
704 CATARACT 62 0.0010
705 SWELLING 97 0.0010
706 FEEDING DISORDER 21 0.0010
707 LYMPHOMA 16 0.0010
708 SINUS BRADYCARDIA 10 0.0010
709 GYNAECOMASTIA 32 0.0010
710 DEAFNESS 27 0.0010
711 GASTRIC CANCER 26 0.0010
712 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
713 SEIZURE 118 0.0010
714 CORONARY ARTERY OCCLUSION 14 0.0010
715 INTRAOCULAR PRESSURE INCREASED 13 0.0010
716 FEELING ABNORMAL 243 0.0010
717 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
718 SKIN ULCER 26 0.0010
719 GASTROINTESTINAL PAIN 11 0.0010
720 CIRCULATORY COLLAPSE 17 0.0010
721 SENSORY DISTURBANCE 16 0.0010
722 EXTRA DOSE ADMINISTERED 40 0.0010
723 PRODUCTIVE COUGH 47 0.0010
724 SOMNOLENCE 198 0.0010
725 INTENTIONAL DOSE OMISSION 28 0.0010
726 INSURANCE ISSUE 15 0.0010
727 BRADYCARDIA 52 0.0010
728 MYELOSUPPRESSION 35 0.0010
729 GASTROINTESTINAL DISORDER 87 0.0010
730 TEMPERATURE INTOLERANCE 10 0.0010
731 ANKLE FRACTURE 15 0.0010
732 HEART RATE DECREASED 34 0.0010
733 HAEMOPTYSIS 27 0.0010
734 NECK PAIN 54 0.0010
735 PALPITATIONS 113 0.0010
736 FLUID OVERLOAD 14 0.0010
737 BLISTER 54 0.0010
738 COAGULOPATHY 16 0.0010
739 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 192 0.0009
740 DEPRESSED MOOD 50 0.0009
741 ABDOMINAL PAIN 220 0.0009
742 CHOLELITHIASIS 31 0.0009
743 VASCULITIS 11 0.0009
744 STOMATITIS 57 0.0009
745 BLOOD GLUCOSE DECREASED 45 0.0009
746 POOR QUALITY SLEEP 20 0.0009
747 DECREASED ACTIVITY 10 0.0009
748 LUNG NEOPLASM MALIGNANT 38 0.0009
749 PARKINSONISM 9 0.0009
750 MACULAR DEGENERATION 11 0.0009
751 HYPERLIPIDAEMIA 11 0.0009
752 INFUSION RELATED REACTION 61 0.0009
753 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
754 DIALYSIS 13 0.0009
755 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
756 SHOCK 21 0.0009
757 DRUG ADMINISTRATION ERROR 28 0.0009
758 COLD SWEAT 16 0.0009
759 GASTROOESOPHAGEAL REFLUX DISEASE 73 0.0009
760 DENTAL CARIES 10 0.0009
761 PHOTOPHOBIA 17 0.0009
762 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
763 COUGH 251 0.0009
764 TOXIC SKIN ERUPTION 9 0.0009
765 MUSCULOSKELETAL DISORDER 17 0.0009
766 FREQUENT BOWEL MOVEMENTS 24 0.0009
767 HAEMATOMA 23 0.0009
768 CHOLESTASIS 17 0.0009
769 LOWER LIMB FRACTURE 17 0.0009
770 CARDIOMYOPATHY 13 0.0009
771 GINGIVAL BLEEDING 12 0.0009
772 ERUCTATION 17 0.0009
773 SCAB 10 0.0009
774 SKIN DISORDER 29 0.0009
775 TOOTH LOSS 18 0.0009
776 PULMONARY HYPERTENSION 18 0.0009
777 TYPE 2 DIABETES MELLITUS 29 0.0009
778 APHASIA 26 0.0009
779 POST PROCEDURAL HAEMORRHAGE 10 0.0009
780 ENCEPHALOPATHY 21 0.0009
781 SEXUAL DYSFUNCTION 10 0.0009
782 UNRESPONSIVE TO STIMULI 22 0.0009
783 HYPOXIA 30 0.0009
784 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
785 SEASONAL ALLERGY 12 0.0008
786 PROTEINURIA 16 0.0008
787 VIRAL INFECTION 28 0.0008
788 IMMUNE SYSTEM DISORDER 11 0.0008
789 WRIST FRACTURE 10 0.0008
790 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
791 BASAL CELL CARCINOMA 13 0.0008
792 TACHYCARDIA 74 0.0008
793 HAEMATEMESIS 21 0.0008
794 PRODUCT DISPENSING ERROR 18 0.0008
795 APATHY 12 0.0008
796 NEURALGIA 20 0.0008
797 IMPAIRED HEALING 27 0.0008
798 UNDERDOSE 60 0.0008
799 SINUS CONGESTION 11 0.0008
800 PALLOR 22 0.0008
801 TINNITUS 37 0.0008
802 DYSARTHRIA 30 0.0008
803 TREMOR 132 0.0008
804 RASH 346 0.0008
805 RASH PRURITIC 43 0.0008
806 HEADACHE 497 0.0008
807 RESTLESSNESS 29 0.0008
808 CHOLECYSTECTOMY 9 0.0008
809 GALLBLADDER DISORDER 14 0.0008
810 BLINDNESS UNILATERAL 11 0.0008
811 HIATUS HERNIA 10 0.0008
812 MOOD ALTERED 21 0.0008
813 C-REACTIVE PROTEIN INCREASED 28 0.0008
814 CARDIO-RESPIRATORY ARREST 32 0.0008
815 PARAESTHESIA 120 0.0008
816 RESPIRATORY ARREST 21 0.0008
817 RESPIRATORY DISTRESS 21 0.0008
818 ORAL PAIN 17 0.0008
819 PRODUCT DOSE OMISSION ISSUE 223 0.0008
820 THINKING ABNORMAL 14 0.0008
821 MENTAL IMPAIRMENT 18 0.0007
822 CHEST DISCOMFORT 76 0.0007
823 UNEVALUABLE EVENT 56 0.0007
824 PANCREATITIS 39 0.0007
825 ILLNESS 76 0.0007
826 HEAD DISCOMFORT 13 0.0007
827 RASH GENERALISED 19 0.0007
828 SLEEP APNOEA SYNDROME 14 0.0007
829 HYPOAESTHESIA ORAL 11 0.0007
830 BRONCHITIS 54 0.0007
831 PERIPHERAL COLDNESS 10 0.0007
832 LACRIMATION INCREASED 22 0.0007
833 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
834 METABOLIC ACIDOSIS 23 0.0007
835 SECRETION DISCHARGE 9 0.0007
836 FEELING HOT 44 0.0007
837 VISION BLURRED 98 0.0007
838 SKIN REACTION 10 0.0007
839 BLOOD CHOLESTEROL INCREASED 33 0.0007
840 DEPRESSION 161 0.0007
841 CONDITION AGGRAVATED 215 0.0007
842 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
843 MUSCULOSKELETAL STIFFNESS 61 0.0007
844 MULTI-ORGAN FAILURE 12 0.0007
845 PRODUCT USE ISSUE 130 0.0007
846 HALLUCINATION 52 0.0007
847 PRODUCT USE IN UNAPPROVED INDICATION 171 0.0007
848 MUCOSAL INFLAMMATION 18 0.0007
849 SPEECH DISORDER 36 0.0007
850 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
851 JOINT STIFFNESS 18 0.0007
852 INCORRECT PRODUCT STORAGE 9 0.0007
853 EOSINOPHILIA 12 0.0007
854 NASOPHARYNGITIS 126 0.0007
855 OXYGEN SATURATION DECREASED 38 0.0007
856 RHINORRHOEA 43 0.0007
857 OSTEOPENIA 10 0.0007
858 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
859 WOUND 18 0.0006
860 INFLUENZA LIKE ILLNESS 53 0.0006
861 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
862 HEPATIC CIRRHOSIS 12 0.0006
863 TOXICITY TO VARIOUS AGENTS 107 0.0006
864 FEELING JITTERY 12 0.0006
865 HEPATIC CANCER 15 0.0006
866 HYPERTHYROIDISM 9 0.0006
867 DERMATITIS 13 0.0006
868 LIMB DISCOMFORT 19 0.0006
869 NERVOUS SYSTEM DISORDER 19 0.0006
870 SINUS DISORDER 12 0.0006
871 CHRONIC KIDNEY DISEASE 46 0.0006
872 INFLAMMATION 31 0.0006
873 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
874 MEDICATION ERROR 33 0.0006
875 CANDIDA INFECTION 10 0.0006
876 DRUG DISPENSING ERROR 9 0.0006
877 EPILEPSY 18 0.0006
878 ARTHRITIS 46 0.0006
879 DRY SKIN 78 0.0006
880 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
881 DIABETIC KETOACIDOSIS 14 0.0006
882 IRRITABILITY 35 0.0006
883 FOOT FRACTURE 11 0.0006
884 ABNORMAL DREAMS 16 0.0006
885 STAPHYLOCOCCAL INFECTION 19 0.0006
886 ACCIDENTAL OVERDOSE 21 0.0006
887 DISCOMFORT 35 0.0006
888 OESOPHAGEAL CARCINOMA 17 0.0006
889 PRODUCT AVAILABILITY ISSUE 13 0.0006
890 MUSCLE TIGHTNESS 9 0.0006
891 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
892 RASH MACULAR 19 0.0005
893 LIP SWELLING 18 0.0005
894 FLUSHING 54 0.0005
895 MOVEMENT DISORDER 17 0.0005
896 INJURY 37 0.0005
897 ARTHROPATHY 29 0.0005
898 EYE DISORDER 17 0.0005
899 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
900 SYRINGE ISSUE 9 0.0005
901 SKIN EXFOLIATION 43 0.0005
902 OROPHARYNGEAL PAIN 47 0.0005
903 DISABILITY 10 0.0005
904 RENAL INJURY 15 0.0005
905 HYPOTHYROIDISM 16 0.0005
906 DISTURBANCE IN ATTENTION 27 0.0005
907 BLINDNESS 20 0.0005
908 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
909 PRODUCT SUBSTITUTION ISSUE 28 0.0005
910 EYE SWELLING 18 0.0005
911 SWOLLEN TONGUE 15 0.0005
912 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
913 ALOPECIA 94 0.0005
914 VISUAL IMPAIRMENT 59 0.0005
915 MOUTH ULCERATION 10 0.0005
916 CRYING 17 0.0005
917 URTICARIA 78 0.0005
918 EAR PAIN 9 0.0005
919 ILL-DEFINED DISORDER 28 0.0005
920 NERVOUSNESS 24 0.0005
921 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
922 STEVENS-JOHNSON SYNDROME 10 0.0004
923 THROAT IRRITATION 20 0.0004
924 DYSPHONIA 26 0.0004
925 PRURITUS 170 0.0004
926 BURNING SENSATION 31 0.0004
927 BLADDER CANCER 26 0.0004
928 DRUG EFFECT INCOMPLETE 16 0.0004
929 PERITONITIS 9 0.0004
930 ERYTHEMA 89 0.0004
931 ANGIOEDEMA 19 0.0004
932 ABNORMAL BEHAVIOUR 17 0.0004
933 KNEE ARTHROPLASTY 9 0.0004
934 OSTEOARTHRITIS 18 0.0004
935 IMPAIRED WORK ABILITY 9 0.0004
936 SINUSITIS 43 0.0004
937 RASH ERYTHEMATOUS 20 0.0004
938 EAR INFECTION 11 0.0004
939 THROAT TIGHTNESS 11 0.0004
940 PSYCHOTIC DISORDER 12 0.0004
941 INJECTION SITE MASS 15 0.0004
942 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
943 ECZEMA 21 0.0004
944 SNEEZING 9 0.0004
945 SKIN LESION 11 0.0004
946 DISEASE RECURRENCE 19 0.0004
947 COMA 19 0.0004
948 NASAL CONGESTION 23 0.0004
949 MUSCLE TWITCHING 9 0.0004
950 FUNGAL INFECTION 13 0.0004
951 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
952 BONE DENSITY DECREASED 12 0.0004
953 AGITATION 28 0.0004
954 PANCREATIC CARCINOMA 11 0.0004
955 DYSKINESIA 15 0.0004
956 MENTAL DISORDER 16 0.0004
957 ANXIETY 104 0.0004
958 EYE PAIN 20 0.0004
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
960 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
961 ANGER 11 0.0003
962 AGGRESSION 16 0.0003
963 NIGHTMARE 11 0.0003
964 PANIC ATTACK 11 0.0003
965 HYPERSENSITIVITY 55 0.0003
966 PRODUCT STORAGE ERROR 25 0.0003
967 PLASMA CELL MYELOMA 11 0.0003
968 OCULAR HYPERAEMIA 13 0.0003
969 EXPIRED PRODUCT ADMINISTERED 9 0.0003
970 WITHDRAWAL SYNDROME 11 0.0003
971 DRY EYE 13 0.0003
972 ANAPHYLACTIC REACTION 14 0.0003
973 INTENTIONAL PRODUCT MISUSE 22 0.0003
974 SUICIDAL IDEATION 23 0.0003
975 DEVICE LEAKAGE 10 0.0002
976 MIGRAINE 22 0.0002
977 COLORECTAL CANCER 11 0.0002
978 CONVULSION 13 0.0002
979 EYE IRRITATION 13 0.0002
980 OVERDOSE 45 0.0002
981 DEVICE DISLOCATION 9 0.0002
982 WHEEZING 12 0.0002
983 PRODUCT QUALITY ISSUE 24 0.0002
984 EXPOSURE DURING PREGNANCY 10 0.0002
985 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
986 INJECTION SITE PAIN 46 0.0001
987 DRUG DEPENDENCE 20 0.0001
988 NO ADVERSE EVENT 19 0.0001
989 EMOTIONAL DISTRESS 11 0.0001
990 ASTHMA 10 0.0001
991 INJECTION SITE ERYTHEMA 10 0.0001